Vraylar
What is Vraylar (Cariprazine)?
Approved To Treat
Related Clinical Trials
Summary: Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of depressive episodes in bipolar disorder in adults, therefore pharmacotherapeutic options are limited. Gi...
Summary: The purpose of this study is to assess the PK, Safety, Tolerability (all cohorts) and Efficacy (cohort 3), of once-a-month long-acting SC injection of dose escalating Cariprazine Depot in subjects eligible for treatment with oral Cariprazine.
Summary: The purpose of this research is to understand how changes in RNA editing relate to treatment response in unipolar and bipolar depression.

